Rakovina v \u010cesku z\u016fst\u00e1v\u00e1 jedn\u00edm z hlavn\u00edch zdravotn\u00edch probl\u00e9m\u016f, a\u010dkoliv se v posledn\u00edch letech poda\u0159ilo v\u00fdrazn\u011b zlep\u0161it p\u0159edpov\u011bdi pro mnoh\u00e9 typy onemocn\u011bn\u00ed. Podle N\u00e1rodn\u00edho \u00fastavu l\u00e9ka\u0159sk\u00e9 v\u00fdzkumu je v\u0161ak v sou\u010dasnosti ka\u017edoro\u010dn\u011b diagnostikov\u00e1no p\u0159es 80 000 nov\u00fdch p\u0159\u00edpad\u016f, p\u0159i\u010dem\u017e n\u00e1klady na l\u00e9\u010dbu se pohybuj\u00ed v \u0159\u00e1du des\u00edtek miliard korun ro\u010dn\u011b. V\u011bt\u0161ina z nich pad\u00e1 na chemoterapii, radioterapii a c\u00edlenou terapii, kter\u00e9 jsou v \u010cesku \u010dasto dra\u017e\u0161\u00ed ne\u017e v sousedn\u00edch zem\u00edch, co\u017e zt\u011b\u017euje p\u0159\u00edstup k l\u00e9\u010db\u011b pro pacienty s n\u00edzk\u00fdm p\u0159\u00edjmem.<\/p>\n
V\u00fdzkumy ukazuj\u00ed, \u017ee nap\u0159\u00edklad l\u00e9\u010dba imunoterapi\u00ed, kter\u00e1 se st\u00e1v\u00e1 standardem u n\u011bkter\u00fdch typ\u016f rakoviny, m\u016f\u017ee st\u00e1t a\u017e 100 000 a\u017e 200 000 korun za jeden m\u011bs\u00edc. V porovn\u00e1n\u00ed s N\u011bmeckem nebo Rakouskem, kde podobn\u00e9 terapie stoj\u00ed p\u0159ibli\u017en\u011b polovinu, se \u010desk\u00e1 cena pohybuje v nadstandardn\u00edch mez\u00edch. Tento rozd\u00edl je \u010dasto spojov\u00e1n s vy\u0161\u0161\u00edmi n\u00e1klady na import l\u00e9\u010div, kter\u00e9 jsou v \u010cesku regulov\u00e1ny st\u00e1tem, a tak\u00e9 s nedostatkem konkurence mezi farmaceutick\u00fdmi firmami.<\/p>\n
Podle studie \u00dastavu zdravotnick\u00fdch informac\u00ed a statistiky \u010cR \u010din\u00ed celkov\u00e9 v\u00fddaje na l\u00e9\u010dbu rakoviny v \u010cesku p\u0159ibli\u017en\u011b 12 miliard korun ro\u010dn\u011b. Z toho 70 procent p\u0159ipad\u00e1 na ambulantn\u00ed a hospitaliza\u010dn\u00ed p\u00e9\u010di, zat\u00edmco 30 procent na l\u00e9\u010debn\u00e9 postupy. V\u011bt\u0161ina z t\u011bchto n\u00e1klad\u016f je hrazen\u00e1 ze zdravotn\u00edho poji\u0161t\u011bn\u00ed, av\u0161ak pro pacienty s chronick\u00fdm onemocn\u011bn\u00edm nebo n\u00edzk\u00fdm p\u0159\u00edjmem se \u010dasto st\u00e1v\u00e1, \u017ee se jedn\u00e1 o p\u0159\u00edm\u00e9 n\u00e1klady, kter\u00e9 mohou b\u00fdt pro n\u011b ne\u00fanosn\u00e9.<\/p>\n
Jedn\u00edm z kl\u00ed\u010dov\u00fdch probl\u00e9m\u016f je tak\u00e9 nedostatek specializovan\u00fdch l\u00e9ka\u0159sk\u00fdch za\u0159\u00edzen\u00ed a odborn\u00edk\u016f. V n\u011bkter\u00fdch regionech \u010cR existuje nedostatek onkolog\u016f, radioterapeut\u016f nebo l\u00e9ka\u0159\u016f specializuj\u00edc\u00edch se na c\u00edlenou terapii, co\u017e m\u016f\u017ee v\u00e9st k prodlu\u017eov\u00e1n\u00ed l\u00e9\u010debn\u00fdch proces\u016f a zv\u00fd\u0161en\u00ed n\u00e1klad\u016f. Podle dat \u010desk\u00e9ho zdravotn\u00edho syst\u00e9mu je nap\u0159\u00edklad v Praze o 40 procent m\u00e9n\u011b radioterapeut\u016f na 100 000 obyvatel ne\u017e v Moravskoslezsk\u00e9m kraji, co\u017e m\u016f\u017ee ovlivnit \u010das a n\u00e1klady na l\u00e9\u010dbu.<\/p>\n
V souvislosti s vysok\u00fdmi n\u00e1klady na l\u00e9\u010dbu rakoviny se v posledn\u00edch letech objevuj\u00ed tak\u00e9 iniciativy, kter\u00e9 cht\u011bj\u00ed \u0159e\u0161it tento probl\u00e9m z r\u016fzn\u00fdch \u00fahl\u016f. Nap\u0159\u00edklad \u010cesk\u00e1 spole\u010dnost pro onkologii podporuje projekty, kter\u00e9 zkoumaj\u00ed mo\u017enosti redukce n\u00e1klad\u016f na l\u00e9\u010dbu, nap\u0159\u00edklad prost\u0159ednictv\u00edm generick\u00fdch l\u00e9k\u016f nebo alternativn\u00edch l\u00e9\u010debn\u00fdch postup\u016f. odkaz zde<\/a> ukazuje, jak n\u011bkter\u00e9 evropsk\u00e9 zem\u011b \u0159e\u0161\u00ed podobn\u00e9 probl\u00e9my prost\u0159ednictv\u00edm spole\u010dn\u00fdch zak\u00e1zek a standardizovan\u00fdch postup\u016f.<\/p>\n Dal\u0161\u00edm aspektem je tak\u00e9 role zdravotn\u00ed poji\u0161\u0165ovny a jej\u00ed schopnost efektivn\u011b \u0159\u00eddit n\u00e1klady. V n\u011bkter\u00fdch p\u0159\u00edpadech se uk\u00e1zalo, \u017ee poji\u0161\u0165ovny mohou sn\u00ed\u017eit n\u00e1klady na l\u00e9\u010dbu nap\u0159\u00edklad prost\u0159ednictv\u00edm p\u0159edem stanoven\u00fdch cenov\u00fdch limit\u016f nebo preferenc\u00ed pro ur\u010dit\u00e9 l\u00e9\u010debn\u00e9 postupy. Nicm\u00e9n\u011b v praxi se \u010dasto setk\u00e1v\u00e1me s odporem odborn\u00edk\u016f a pacient\u016f, kte\u0159\u00ed cht\u011bj\u00ed dostat nejmodern\u011bj\u0161\u00ed l\u00e9\u010dbu bez omezen\u00ed.<\/p>\n Vzhledem k tomu, \u017ee rakovina z\u016fst\u00e1v\u00e1 jedn\u00edm z hlavn\u00edch ekonomick\u00fdch i zdravotn\u00edch probl\u00e9m\u016f, je d\u016fle\u017eit\u00e9 hledat \u0159e\u0161en\u00ed, kter\u00e1 by umo\u017enila pacient\u016fm dostat se k kvalitn\u00ed l\u00e9\u010db\u011b bez finan\u010dn\u00edch obt\u00ed\u017e\u00ed. Jednou z mo\u017enost\u00ed by mohlo b\u00fdt zv\u00fd\u0161en\u00ed transparentnosti cen l\u00e9\u010div, podpora v\u00fdvoje generick\u00fdch l\u00e9k\u016f nebo spolupr\u00e1ce mezi zdravotn\u00edmi poji\u0161\u0165ovnami a farmaceutick\u00fdmi firmami, aby se sn\u00ed\u017eily n\u00e1klady na import.<\/p>\n","protected":false},"excerpt":{"rendered":" Rakovina v \u010cesku z\u016fst\u00e1v\u00e1 jedn\u00edm z hlavn\u00edch zdravotn\u00edch probl\u00e9m\u016f, a\u010dkoliv se v posledn\u00edch letech poda\u0159ilo v\u00fdrazn\u011b zlep\u0161it p\u0159edpov\u011bdi pro mnoh\u00e9 typy onemocn\u011bn\u00ed. Podle N\u00e1rodn\u00edho \u00fastavu l\u00e9ka\u0159sk\u00e9 v\u00fdzkumu je v\u0161ak v sou\u010dasnosti ka\u017edoro\u010dn\u011b diagnostikov\u00e1no p\u0159es 80 000 nov\u00fdch p\u0159\u00edpad\u016f, p\u0159i\u010dem\u017e n\u00e1klady na l\u00e9\u010dbu se pohybuj\u00ed v \u0159\u00e1du des\u00edtek miliard korun ro\u010dn\u011b. V\u011bt\u0161ina z nich pad\u00e1 na […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"categories":[1],"tags":[],"class_list":["post-44010","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/testv36.demowebsitelinks.com\/aconi\/wp-json\/wp\/v2\/posts\/44010","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/testv36.demowebsitelinks.com\/aconi\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/testv36.demowebsitelinks.com\/aconi\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/testv36.demowebsitelinks.com\/aconi\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/testv36.demowebsitelinks.com\/aconi\/wp-json\/wp\/v2\/comments?post=44010"}],"version-history":[{"count":1,"href":"https:\/\/testv36.demowebsitelinks.com\/aconi\/wp-json\/wp\/v2\/posts\/44010\/revisions"}],"predecessor-version":[{"id":44011,"href":"https:\/\/testv36.demowebsitelinks.com\/aconi\/wp-json\/wp\/v2\/posts\/44010\/revisions\/44011"}],"wp:attachment":[{"href":"https:\/\/testv36.demowebsitelinks.com\/aconi\/wp-json\/wp\/v2\/media?parent=44010"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/testv36.demowebsitelinks.com\/aconi\/wp-json\/wp\/v2\/categories?post=44010"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/testv36.demowebsitelinks.com\/aconi\/wp-json\/wp\/v2\/tags?post=44010"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}\n